Member Info for Runner-Runner

It has been well earned by you don't you think MFM?

"Preferred the jumbo to the turbo but the Graham gooch 333 was a belter"

Wow Doggy,

I was at Lords and saw that innings of 333. Tendulkar got a ton that match too. Wow. Over 30 years ago that!

Reality Hunter

"The AVCT RNS's are a masterclass in messaging. Think - have they ever stated that the Saliva test died?"

No, in fact they have stated that the LFT they are producing works with both saliva and AN sample types.

" if you can confirm what exactly AVCT has delivered to increase the SP from £50m MCAP to £700m then be my guest."

They have given investors a remarkable opportunity to get in on an early stage Biotech behemoth. Investors have wholehaeartedly bought in to the risk/reward situation here. Join in or stand on the sidelines spouting nonsense.

Of course.

It was stated that AVA6000 was on time. It isn't. Sorry for posting a fact.

Sorry guys. AVA6000 not on time.

From 18th October 2019 RNS

AVA6000

Avacta expects to file an IND/CTA application by the end of 1Q2020, to dose first patients with AVA6000 Pro-doxorubicin by the end of 2Q2020 with initial read-out expected in 3Q/4Q2020

Robbo

"R&D burns cash"

This is why our business model ensures that our partners pay the majority of R&D costs.

Just because you can leverage with a spread bet. Doesn't mean you have to!

It took 4 weeks when they were short on staff and resources. No doubt a little quicker now if they needed to be.

Just an idea Roly.

Maybe try to make sense of it all BEFORE hitting the buy or sell button next time?

The mighty Avacta rollercoaster ride continues. The traders hop on and off, the weak stagger into the bushes to vomit and the contented LTH's yell, "scream if you wanna go faster!"

Yes, as discussed previously, MCAP still very low here.

Just out of interest Stocktaker, out of all the companies listed on all the global exchanges, why choose NCYT as a comparator. Since the 2 business are completely different?

Was just thinking about this Timster.

How about manufacturers around the globe bidding for a slice, but using our test. We know the 8 billion supplies far more capacity than all our known manufacturing partners can produce.

This could be the Gov't basically doing the licensing deals for us.

Thoughts anyone?

The interesting thing to consider here regarding the ODX contract is Tech Transfer.

They appear only to be waiting for CV to pass, then they will get the manufacturing contract, suggesting very strongly that any Tech Transfer issues must be completed already so that they can beging manufacture quickly.

Strongly suggests then that if this our test the gov is waiting for that Tech Transfer is done and dusted already with our own manufacturers also.

Yes Trendz,

We know what your view is based on. We also know that this is the wrong way to view this company. And to be fair, we have tried to help you understand that.

Trendz

We get many posts here along those lines. Suffice to say that the reality here is that

Avacta is way, way, way UNDERPRICED for perfection, if perfection is success in all their many and varied pipelines and collaborations. If that were to actually happen many multiples of todays MCAP would be acheived.

You are just looking at Avacta from the Covid angle as so many of the poorly researched "naysayers" of this stock do.

Everything you need to know is out their in plain sight.

DYOR

Blimey,

Pretty sure SISU's post was a counter to SheerStupid's nonsense.

It never ceases to amaze me how many people out there go to such great lengths to show off their frightening stupidity.

Please stand in the corner facing the wall Sheerclass, while I fetch the dunce hat for you.

FOMO getting real here now.

"Am I reading this correctly that doxorubicin trials will be using affimers?"

No.

Is the current market cap only pricing in covid test potential. Or is it only pricing in everything else, cos it sure aint pricing in both at the moment!

Get the LFT over the line and (to borrow a Sujoodism) it's gonna go mental!

Lol